Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) EBT Margin: 2016-2025

Historic EBT Margin for Collegium Pharmaceutical (COLL) over the last 10 years, with Sep 2025 value amounting to 20.75%.

  • Collegium Pharmaceutical's EBT Margin rose 1097.00% to 20.75% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.68%, marking a year-over-year decrease of 1068.00%. This contributed to the annual value of 15.61% for FY2024, which is 225.00% up from last year.
  • According to the latest figures from Q3 2025, Collegium Pharmaceutical's EBT Margin is 20.75%, which was up 129.10% from 9.06% recorded in Q2 2025.
  • Collegium Pharmaceutical's EBT Margin's 5-year high stood at 31.19% during Q4 2023, with a 5-year trough of -142.08% in Q4 2021.
  • In the last 3 years, Collegium Pharmaceutical's EBT Margin had a median value of 13.13% in 2023 and averaged 13.58%.
  • As far as peak fluctuations go, Collegium Pharmaceutical's EBT Margin tumbled by 15,160bps in 2021, and later soared by 13,607bps in 2022.
  • Collegium Pharmaceutical's EBT Margin (Quarterly) stood at -142.08% in 2021, then spiked by 13,607bps to -6.01% in 2022, then skyrocketed by 3,720bps to 31.19% in 2023, then plummeted by 2,170bps to 9.49% in 2024, then soared by 1,097bps to 20.75% in 2025.
  • Its last three reported values are 20.75% in Q3 2025, 9.06% for Q2 2025, and 1.76% during Q1 2025.